DRG:HYBRiD-XL® Summer Workshop Recap
On June 4th-6th, the DRG:HYBRiD-XL Summer workshop took place in Germany with distributors from Nepal, Lebanon, and Australia. It was a very enthusiastic group! Key topics discussed included real situations in the field and Hepcidin as a new biomarker. Attendees felt they left the workshop with valuable information regarding the analyzers, Calprotectin, user maintenance, priming functions, and much more useful knowledge.
Thank you to all who helped make this workshop a success. Thank you to our colleagues: Julia Raeder, Stefanie Lamers, Birgit Burk, Sarah Schmidt, Sophie Pitton, Petra Zienecker, Wilhelm Sänger, Dr. Bernd Roeder, Dr. Matthias Herkert, Rene Linke, and Volker Laucht for their involvement in the workshop.
Special thanks to Oleg Vishnevski, Dr. Hero Brahms, Marco Euler, Keyvan Shabani, and our trainees (pictured above).
News and Updates
The growth and further development of the North American market is a key priority for us and the sole focus of the new Sales and Business Development Executive we are looking to recruit.
On April 30th, 2020, an organized study by Radboud University Medical Center in Nijmegen, Netherlands, has completed a final report for the DRG International’s first ever Hepcidin Proficiency Test.
The Stifterverband für die Deutsche Wissenschaft honors the research activities of DRG Instruments GmbH with the “Innovative Through Research” seal of approval…